Sakado, Japan

Takao Abe

This inventor holds 6 USPTO granted patents. Top assignee: Lederle (Japan), Ltd.. Active years: 1993-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takao Abe. Retrieved from https://idiyas.com/inventor/takao-abe-8pwm09qb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Tokorozawa, JP (1993 - 1995)
  • Sakado, JP (1996 - 1999)

Company Filing History:


Years Active: 1993-1999

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Takao Abe

Introduction

Takao Abe is a notable inventor based in Sakado, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotic compounds. With a total of six patents to his name, Abe's work has had a considerable impact on the treatment of bacterial infections.

Latest Patents

Abe's latest patents include innovative carbapenem-3-carboxylic acid ester derivatives. These compounds are designed to serve as effective antibiotics for the prevention and treatment of bacterial infections. One of the embodiments of his invention relates to novel carbapenem compounds, specifically (1R, 5S, 6S)-2-[(1,3-thiazolin-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxy-ethyl]-1-methylcarbapen-2-em-3-carboxylic acid derivatives. These compounds are characterized by a beta-coordinated methyl group at the 1-position and a thio group at the 2-position. The compounds are represented by a specific formula, where R can be hydrogen or a lower alkyl group, and Y can be carboxy or protected carboxy. Additionally, his second embodiment involves 3-mercapto-1-(1,3-thiazolin-2-yl)azetidine and its acid addition salts, which are useful intermediates for preparing carbapenem compounds with strong antibacterial activity.

Career Highlights

Takao Abe is currently associated with Lederle (Japan), Ltd., where he continues to innovate in the field of antibiotic development. His work has been instrumental in advancing the understanding and application of carbapenem compounds in medical treatments.

Collaborations

Abe has collaborated with notable colleagues such as Satoshi Tamai and Toshio Kumagai. Their combined expertise has contributed to the successful development of new pharmaceutical compounds.

Conclusion

Takao Abe's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a significant inventor in the fight against bacterial infections. His work continues to influence the development of effective antibiotics, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…